These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37129505)

  • 1. Factors contributing to development and resolution of dysglycemia in patients with pheochromocytomas and catecholamine-secreting paragangliomas.
    Zhao L; Zhang T; Meng X; Zhang Z; Zhou Y; Fan H; Liu Y; Zhou X; Zhu H
    Ann Med; 2023 Dec; 55(1):2203945. PubMed ID: 37129505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical differences between small and large pheochromocytomas and paragangliomas.
    Zhao L; Li Z; Meng X; Fan H; Zhang Z; Zhang Z; Liu Y; Zhou X; Zhu H
    Front Endocrinol (Lausanne); 2023; 14():1087506. PubMed ID: 36967797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical characteristics of patients with normotension in pheochromocytomas and paragangliomas.
    Zhao L; Zhang T; Meng X; Fan H; Zhang Z; Liu Y; Zhou X; Zhu H
    Endocrine; 2023 Apr; 80(1):174-182. PubMed ID: 36749542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical Resection of Pheochromocytomas and Paragangliomas is Associated with Lower Cholesterol Levels.
    Good ML; Malekzadeh P; Ruff SM; Gupta S; Copeland A; Pacak K; Nilubol N; Kebebew E; Patel D
    World J Surg; 2020 Feb; 44(2):552-560. PubMed ID: 31531722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a novel nomogram predicting pseudohypoxia type pheochromocytomas and paragangliomas.
    Wang Y; Liu L; Chen D; Pang Y; Xu X; Liu J; Li M; Guan X
    J Endocrinol Invest; 2023 Jul; 46(7):1361-1371. PubMed ID: 36508127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid Excess in Patients with Pheochromocytoma Compared with Paraganglioma and Other Forms of Hypertension.
    Constantinescu G; Langton K; Conrad C; Amar L; Assié G; Gimenez-Roqueplo AP; Blanchard A; Larsen CK; Mulatero P; Williams TA; Prejbisz A; Fassnacht M; Bornstein S; Ceccato F; Fliedner S; Dennedy M; Peitzsch M; Sinnott R; Januszewicz A; Beuschlein F; Reincke M; Zennaro MC; Eisenhofer G; Deinum J
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3374-83. PubMed ID: 32609829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Cardiac Complications in Patients With Pheochromocytoma and Paraganglioma: A Retrospective Single-Center Study.
    Zhao L; Meng X; Mei Q; Fan H; Liu Y; Zhou X; Zhu H; Zhang S
    Front Endocrinol (Lausanne); 2022; 13():877341. PubMed ID: 35721724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic disorders in patients with pheochromocytomas and sympathetic paragangliomas.
    Araujo-Castro M; Mínguez Ojeda C; García Centeno R; López-García MC; Lamas C; Hanzu FA; Mora M; Del Castillo Tous M; Rodríguez de Vera Gómez P; Parra Ramírez P; Alvarez-Escola C; Blanco Carrera C; Barahona San Millán R; Recasens M; Valdés N; Gracia Gimeno P; de Miguel Novoa P; Vicente A; Manjón L; García Sanz I; Michalopoulou T; Calatayud M
    Endocr Relat Cancer; 2022 Dec; 29(12):645-655. PubMed ID: 36069783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative intravenous rehydration for patients with pheochromocytomas and paragangliomas: is it necessary? A propensity score matching analysis.
    Kong H; Yang JN; Tian J; Li N; Zhang YX; Ye PC; Li XY; Zhang Z
    BMC Anesthesiol; 2020 Nov; 20(1):294. PubMed ID: 33250060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and Paragangliomas.
    Ruff SM; Ayabe RI; Malekzadeh P; Good ML; Wach MM; Gonzales MK; Tirosh A; Nilubol N; Pacak K; Kebebew E; Patel D
    J Surg Res; 2019 Nov; 243():1-7. PubMed ID: 31146085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonselective Compared With Selective α-Blockade Is Associated With Less Intraoperative Hypertension in Patients With Pheochromocytomas and Paragangliomas: A Retrospective Cohort Study With Propensity Score Matching.
    Kong H; Li N; Yang XC; Nie XL; Tian J; Wang DX
    Anesth Analg; 2021 Jan; 132(1):140-149. PubMed ID: 32675634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic instability during percutaneous ablation of extra-adrenal metastases of pheochromocytoma and paragangliomas: a case series.
    Deljou A; Kohlenberg JD; Weingarten TN; Bancos I; Young WF; Schroeder DR; Martin DP; Sprung J
    BMC Anesthesiol; 2018 Nov; 18(1):158. PubMed ID: 30400849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical profiles of patients with surgically resected pheochromocytoma and paraganglioma.
    Lee SH; Park JH; Lee JY; Lee SR; Rhee KS; Chae JK; Kim WH; Sul JY; Oh JK; Kwon HJ; Lee JH; Seong IW
    Korean J Intern Med; 2020 Mar; 35(2):351-359. PubMed ID: 30808127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Intraoperative Hemodynamic Instability in Postoperatively Diagnosed Pheochromocytoma and Sympathetic Paraganglioma Patients.
    Kim JH; Lee HC; Kim SJ; Lee KE; Jung KC
    Front Endocrinol (Lausanne); 2022; 13():816833. PubMed ID: 35282440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in intraoperative and surgical outcomes between normotensive pheochromocytomas and sympathetic paragangliomas (PPGLs) and hypertensive PPGLs: results from the PHEO-RISK STUDY.
    Araujo-Castro M; García Sanz I; Mínguez Ojeda C; Calatayud M; Hanzu F; Mora M; Vicente A; Blanco Carrera C; De Miguel Novoa P; López García MDC; Manjón-Miguélez L; Rodríguez de Vera P; Del Castillo Tous M; Barahona San Millán R; Recasens M; Tomé Fernández-Ladreda M; Valdés N; Gracia Gimeno P; Robles Lazaro C; Michalopoulou T; Álvarez Escolá C; García Centeno R; Lamas C
    J Endocrinol Invest; 2023 Apr; 46(4):805-814. PubMed ID: 36323983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Predictors of Prolonged Hypotension After Open Surgery for Pheochromocytomas and Paragangliomas.
    Kong H; Li N; Tian J; Li XY
    World J Surg; 2020 Nov; 44(11):3786-3794. PubMed ID: 32691105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection.
    Kinney MA; Warner ME; vanHeerden JA; Horlocker TT; Young WF; Schroeder DR; Maxson PM; Warner MA
    Anesth Analg; 2000 Nov; 91(5):1118-23. PubMed ID: 11049893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicion.
    Geroula A; Deutschbein T; Langton K; Masjkur J; Pamporaki C; Peitzsch M; Fliedner S; Timmers HJLM; Bornstein SR; Beuschlein F; Stell A; Januszewicz A; Prejbisz A; Fassnacht M; Lenders JWM; Eisenhofer G
    Eur J Endocrinol; 2019 Oct; 181(4):409-420. PubMed ID: 31370000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service.
    Kim JH; Moon H; Noh J; Lee J; Kim SG
    Endocrinol Metab (Seoul); 2020 Mar; 35(1):157-164. PubMed ID: 32207276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management.
    Jain A; Baracco R; Kapur G
    Pediatr Nephrol; 2020 Apr; 35(4):581-594. PubMed ID: 30603807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.